======= PLA2G2E =======
== Gene Information ==
* **Official Symbol**: PLA2G2E
* **Official Name**: phospholipase A2 group IIE
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30814|30814]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZK7|Q9NZK7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PLA2G2E&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLA2G2E|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/618320|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. Has a preference for arachidonic-containing phospholipids.
|Phospholip A2 1|
|low-density lipoprotein particle remodeling|
|calcium-dependent phospholipase A2 activity|
|phosphatidylinositol acyl-chain remodeling|
|phosphatidylglycerol acyl-chain remodeling|
|phosphatidylserine acyl-chain remodeling|
|arachidonate transport|
|arachidonic acid secretion|
|phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)|
|phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)|
|phosphatidylethanolamine acyl-chain remodeling|
|phosphatidylcholine acyl-chain remodeling|
|icosanoid secretion|
|phospholipase A2 activity|
|plasma lipoprotein particle remodeling|
|protein-lipid complex remodeling|
|protein-containing complex remodeling|
|phosphatidylglycerol metabolic process|
|fatty acid derivative transport|
|icosanoid transport|
|phosphatidylserine metabolic process|
|phosphatidic acid biosynthetic process|
|phosphatidic acid metabolic process|
|plasma lipoprotein particle organization|
|protein-lipid complex subunit organization|
|long-chain fatty acid transport|
|regulation of plasma lipoprotein particle levels|
|fatty acid transport|
|phosphatidylcholine metabolic process|
|acid secretion|
|phospholipid binding|
|monocarboxylic acid transport|
|phosphatidylinositol metabolic process|
|ammonium ion metabolic process|
|cellular modified amino acid metabolic process|
|glycerophospholipid biosynthetic process|
|glycerolipid biosynthetic process|
|phospholipid biosynthetic process|
|carboxylic acid transport|
|organic acid transport|
|lipid transport|
|lipid catabolic process|
|glycerophospholipid metabolic process|
|lipid localization|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|extracellular structure organization|
|organic anion transport|
|inflammatory response|
|organophosphate biosynthetic process|
|lipid biosynthetic process|
|anion transport|
|calcium ion binding|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|secretion|
|lipid metabolic process|
|defense response|
|ion transport|
|organic substance catabolic process|
|protein-containing complex subunit organization|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp326|CCT251545 20μM R07 exp326]]|1.73|
|[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|1.87|
|[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.02|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13094
* **Expression level (log2 read counts)**: -6.6
{{:chemogenomics:nalm6 dist.png?nolink |}}